The enzyme ataxia-telangiectasia mutated (ATM) kinase is a key mediator of DDR, and its inhibition has become an attractive therapeutic concept in cancer therapy for the sensitization of cancer cells to chemotherapeutic drugs. The gene discussed is ATM; the disease is cancer.